Skip to Main Content

Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Maternal Peripheral Blood

  • Study HIC#:2000030949
  • Last Updated:02/17/2022

The purpose of this study is to develop a risk-free noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by studying fetal cells in maternal blood. 

  • Age18 years and older
  • GenderFemale only
  • Start Date01/31/2022
  • End Date12/31/2022

Trial Purpose and Description

The purpose of this study is to develop a risk-free noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by studying fetal cells in maternal blood. 

Eligibility Criteria

Eligibility Criteria:

  • >/= 18yo, singleton or twin gestation
  • planning to undergo CVS or amniocentesis

For more information about this study, contact:

Or contact the Help us Discover team on: